Live feed
Filing
SC 13D
SC 13D0000950103-18-014700·Mereo BioPharma Group plc
Schedule 13D ownership disclosure
ONCOMED PHARMACEUTICALS INC
Security class unavailable · CUSIP: 68234X102
Event date: 2018-12-05
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 10.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000950103-18-014700
- Form type
- SC 13D
- Filer
- Mereo BioPharma Group plc
- CIK
- CIK 1719714
- Filed
- Dec 17, 2018
- Reporting period
- Dec 05, 2018
- Description
- Schedule 13D beneficial ownership